A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Smith, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier Epicura - Clinique Louis Caty de Baudour
Baudour, Belgium
- Universitaire Ziekenhuizen (uz) Leuven - Gasthuisberg
Leuven, Belgium
- Chr de la Citadelle
Liège, Belgium
- Kfh Nierenzentrum Coburg
Coburg, Germany
- Gemeinschaftspraxis Und Dialysezentrum Karlstrass
Düsseldorf, Germany
- Kfh Kuratorium Für Dialyse Und Nierentransplantation E.V.
München, Germany
- Kfh Nierenzentrum Rosenheim
Rosenheim, Germany
- Nephrocare Faro
Faro, Portugal
- Hospital de Santa Maria
Lisbon, Portugal
- Nephrocare Portimao
Portimão, Portugal
- Complejo Hospitalario de Torrecardenas
Almería, Spain
- Hospital Clinic of Barcelona
Barcelona, Spain
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Hospital Universitario Reina Sofia
Córdoba, Spain
- Hospital Galdakao-Usansolo
Galdakao, Spain
- Hospital 12 de Octubre
Madrid, Spain
- Servicio de Nefrologia Hospital General Universitario Gregorio Maranon
Madrid, Spain
- Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Madrid, Spain
- Hospital Universitario Marques de Valdecilla
Santander, Cantabria, Spain
- Hospital de Torrevieja
Torrevieja (Alicante), Spain
- Cambridge University Hospitals Nhs Trust
Cambridge, United Kingdom
- Glasgow Royal Infirmary
Glasgow, United Kingdom
- St Georges Healthcare Nhs Trust
London, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2013
- Primary completion
- 31 Aug 2016
- Completion
- 31 Aug 2016
- Last update posted
- 24 Jun 2024
- Registered enrollment
- 50
- Registry id
- NCT01999582
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.